AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75A50119C00032AVAXZIPEN LIMITED
Overview
Award facts
- Net obligations
- $688.86K
- $688,863of $688.86K potential value
- Period of performance
- Apr 2, 2019 to Apr 30, 2021
- Ended
- Modifications
- 2
- Latest action Oct 23, 2020
- Contract type
- Definitive contract
- PIID 75A50119C00032
Description of requirement
ENESI EVALUATION OF NOVEL SOLID DOSE VACCINES FOR USE IN A FUTURE PANDEMIC INFLUENZA
Dates and value
- Award date
- Signed on Apr 2, 2019
- Potential end of performance
- Apr 29, 2021
- Current value
- $688,863Base and exercised options
- Potential value (if all options are exercised)
- $688,863
Obligations by fiscal year of action
- FY2019: $688,863
Total across 1 fiscal year: $688,863
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 23, 2020. View on USAspending · Recipient on SAM.gov
Recipient
LocationABINGDON, GBR
UEIKLMEDM8J3UK3
CAGE codeU1HD7
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org
Parent companyAVAXZIPEN LIMITED
Business types and certifications
For-profit organizationInternational organization
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- 075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- United Kingdom
Classification and competition
Classification
- Product or service (PSC)
- AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- BAA18100SOL00018(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Enesi evaluation of novel solid dose vaccines
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Apr 2, 2019Base obligation at award: $688,863
- Latest action
- Oct 23, 2020 — Other administrative actionModification P00002; administrative: no change in scope or value
- Latest substantive action
- Apr 14, 2020 — Supplemental agreement (within scope)Modification P00001
- Actions by type
- Base award1
- Supplemental agreement (within scope)1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- Environmentally preferableF
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- United kingdomGBR
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 3
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-X-0140-000
- Object classes
- 25.1: Advisory and assistance services